Avoralstat

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameAvoralstat
Drug Alias NameAvoralstatum阿伏司他阿沃司他BCX-VBCX-4161
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasma kallikrein inhibitors
TargetsPlasma kallikrein
Therapy Area/IndicationsDiabetic macular oedemaAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[9
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetic macular oedemaAngioedemas, Hereditary

Other Information

ATC CodeN/A
Related LinksN/A